Skip to main content
Nazia Raja-Khan, MD, Endocrinology, Hershey, PA, Penn State Milton S. Hershey Medical Center

NaziaTrannumRaja-KhanMD

Endocrinology Hershey, PA

Diabetes

Associate Professor, Medicine, Pennsylvania State University College of Medicine

Dr. Raja-Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Raja-Khan's full profile

Already have an account?

Education & Training

  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2007
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2000 - 2003
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2000

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2004 - 2024
  • NY State Medical License
    NY State Medical License 2003 - 2004
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mindfulness-Based Stress Reduction in Women with Overweight or Obesity: A Randomized Clinical Trial  
    Nazia Raja-Khan, MD, Obesity

Press Mentions

  • Trial to Study if Mindfulness Helps with Diabetes-Related Stress, Health
    Trial to Study if Mindfulness Helps with Diabetes-Related Stress, HealthDecember 1st, 2021
  • Type 2 Diabetes Drug May Reduce Risk of Severe COVID-19 Cases
    Type 2 Diabetes Drug May Reduce Risk of Severe COVID-19 CasesSeptember 28th, 2021
  • Drugs Used by Some Type 2 Diabetics May Lessen Risk for Severe COVID-19 Outcomes, Study Suggests
    Drugs Used by Some Type 2 Diabetics May Lessen Risk for Severe COVID-19 Outcomes, Study SuggestsSeptember 27th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations